-
1
-
-
0032821532
-
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications
-
Fox W., Ellard G.A., Mitchison D.A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 3:1999;S231-S279.
-
(1999)
Int J Tuberc Lung Dis
, vol.3
, pp. S231-S279
-
-
Fox, W.1
Ellard, G.A.2
Mitchison, D.A.3
-
2
-
-
0025236718
-
USPHS tuberculosis short-course chemotherapy trial 21: Effectiveness, toxicity, and acceptability
-
Combs D.L., O'Brien R.J., Geiter L.J. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med. 112:1990;397-406.
-
(1990)
Ann Intern Med
, vol.112
, pp. 397-406
-
-
Combs, D.L.1
O'Brien, R.J.2
Geiter, L.J.3
-
3
-
-
0028274105
-
The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis
-
Weis S.E., Slocum P.C., Blais F.X., et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 330:1994;1179-1184.
-
(1994)
N Engl J Med
, vol.330
, pp. 1179-1184
-
-
Weis, S.E.1
Slocum, P.C.2
Blais, F.X.3
-
4
-
-
0025214721
-
A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: A twice-weekly, directly observed, and cost-effective regimen
-
Cohn D.L., Catlin B.J., Peterson K.L., Judson F.N., Sbarbaro J.A. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med. 112:1990;407-415.
-
(1990)
Ann Intern Med
, vol.112
, pp. 407-415
-
-
Cohn, D.L.1
Catlin, B.J.2
Peterson, K.L.3
Judson, F.N.4
Sbarbaro, J.A.5
-
5
-
-
0017550207
-
Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore: The results up to 30 months
-
Singapore Tuberculosis Service/British Medical Research Council. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore: The results up to 30 months. Am Rev Respir Dis 1977; 116: 807-20.
-
(1977)
Am Rev Respir Dis
, vol.116
, pp. 807-820
-
-
-
6
-
-
0023216341
-
In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis
-
Dickinson J.M., Mitchison D.A. In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis. Tubercle. 68:1987;113-118.
-
(1987)
Tubercle
, vol.68
, pp. 113-118
-
-
Dickinson, J.M.1
Mitchison, D.A.2
-
7
-
-
0027744137
-
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice
-
Ji B., Truffot-Pernot C., LaCroix C., et al. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis. 148:1993;1541-1546.
-
(1993)
Am Rev Respir Dis
, vol.148
, pp. 1541-1546
-
-
Ji, B.1
Truffot-Pernot, C.2
LaCroix, C.3
-
9
-
-
0015169660
-
Kinetic studies on rifampicin: Serum concentration analysis in subjects treated with different oral doses over a period of two weeks
-
Acocella G., Pagani V., Marchetti M., Baroni G.C., Nicolis F.B. Kinetic studies on rifampicin: serum concentration analysis in subjects treated with different oral doses over a period of two weeks. Chemotherapy. 16:1971;356-370.
-
(1971)
Chemotherapy
, vol.16
, pp. 356-370
-
-
Acocella, G.1
Pagani, V.2
Marchetti, M.3
Baroni, G.C.4
Nicolis, F.B.5
-
10
-
-
0028226440
-
Treatment of tuberculosis and tuberculosis infection in adults and children
-
Bass J.B.J., Farer L.S., Hopewell P.C., et al. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 149:1994;1359-1374.
-
(1994)
Am J Respir Crit Care Med
, vol.149
, pp. 1359-1374
-
-
Bass, J.B.J.1
Farer, L.S.2
Hopewell, P.C.3
-
11
-
-
0033614603
-
Relapse with rifamycin mono-resistant tuberculosis in HIV-infected patients treated with supervised once-weekly rifapentine and isoniazid
-
Vernon A., Burman W., Benator D., Khan A., Bozeman L. Relapse with rifamycin mono-resistant tuberculosis in HIV-infected patients treated with supervised once-weekly rifapentine and isoniazid. Lancet. 353:1999;1843-1847.
-
(1999)
Lancet
, vol.353
, pp. 1843-1847
-
-
Vernon, A.1
Burman, W.2
Benator, D.3
Khan, A.4
Bozeman, L.5
-
13
-
-
0028125708
-
Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis
-
Cave M.D., Eisenach K.D., Templeton G., et al. Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol. 32:1994;262-266.
-
(1994)
J Clin Microbiol
, vol.32
, pp. 262-266
-
-
Cave, M.D.1
Eisenach, K.D.2
Templeton, G.3
-
14
-
-
0029912504
-
Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis
-
Chaves F., Yang Z., el Hajj H., et al. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol. 34:1996;1118-1123.
-
(1996)
J Clin Microbiol
, vol.34
, pp. 1118-1123
-
-
Chaves, F.1
Yang, Z.2
El Hajj, H.3
-
15
-
-
0031037905
-
The incidence of false-positive cultures of Mycobacterium tuberculosis
-
Burman W.J., Stone B.L., Reves R.R., et al. The incidence of false-positive cultures of Mycobacterium tuberculosis. Am J Respir Crit Care Med. 155:1997;321-326.
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 321-326
-
-
Burman, W.J.1
Stone, B.L.2
Reves, R.R.3
-
16
-
-
0020668953
-
1983 metropolitan height and weight tables
-
1983 metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64: 3-9.
-
(1983)
Stat Bull Metrop Life Found
, vol.64
, pp. 3-9
-
-
-
17
-
-
0018687930
-
A multiple testing procedure for clinical trials
-
O'Brien P.C., Fleming T.C. A multiple testing procedure for clinical trials. Biometrics. 35:1979;549-556.
-
(1979)
Biometrics
, vol.35
, pp. 549-556
-
-
O'Brien, P.C.1
Fleming, T.C.2
-
18
-
-
0018243820
-
Factors affecting relapse following short-course chemotherapy
-
Aber V.R., Nunn A.J. Factors affecting relapse following short-course chemotherapy. Bull Int Union Against Tuberculosis. 53:1978;260-264.
-
(1978)
Bull Int Union Against Tuberculosis
, vol.53
, pp. 260-264
-
-
Aber, V.R.1
Nunn, A.J.2
-
19
-
-
0019155947
-
Short-course (6 month) cooperative tuberculosis study in Poland: Results 18 months after completion of treatment
-
Zierski M., Bek E., Long M.W., Snider D.E. Jr. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis. 122:1980;879-889.
-
(1980)
Am Rev Respir Dis
, vol.122
, pp. 879-889
-
-
Zierski, M.1
Bek, E.2
Long, M.W.3
Snider, D.E.4
-
20
-
-
0027446941
-
Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months
-
Mitchison D.A. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis. 147:1993;1062-1063.
-
(1993)
Am Rev Respir Dis
, vol.147
, pp. 1062-1063
-
-
Mitchison, D.A.1
-
22
-
-
0031807468
-
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis: Initial report
-
Tam C.M., Chan S.L., Lam C.W., et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis: initial report. Am J Respir Crit Care Med. 157:1998;1726-1733.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 1726-1733
-
-
Tam, C.M.1
Chan, S.L.2
Lam, C.W.3
-
24
-
-
0031241141
-
Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong
-
Tam C.M., Chan S.L., Lam C.W., Dickinson J.M., Mitchison D.A. Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. Int J Tuberc Lung Dis. 1:1997;411-416.
-
(1997)
Int J Tuberc Lung Dis
, vol.1
, pp. 411-416
-
-
Tam, C.M.1
Chan, S.L.2
Lam, C.W.3
Dickinson, J.M.4
Mitchison, D.A.5
-
25
-
-
0000387429
-
Low isoniazid (INH) levels are associated with TB treatment failure/relapse with once-weekly rifapentine and INH
-
abstr
-
Weiner M., Khan A., Benator D., Peloquin C., Burman W. Low isoniazid (INH) levels are associated with TB treatment failure/relapse with once-weekly rifapentine and INH. Am J Respir Crit Care Med. 163:2001;A498. (abstr).
-
(2001)
Am J Respir Crit Care Med
, vol.163
, pp. A498
-
-
Weiner, M.1
Khan, A.2
Benator, D.3
Peloquin, C.4
Burman, W.5
-
26
-
-
0031856542
-
Development of rifapentine: The way ahead
-
Mitchison D.A. Development of rifapentine: the way ahead. Int J Tuberc Lung Dis. 2:1998;612-615.
-
(1998)
Int J Tuberc Lung Dis
, vol.2
, pp. 612-615
-
-
Mitchison, D.A.1
-
27
-
-
0025361652
-
Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis
-
Heifets L.B., Lindhom-Levy P., Flory M.A. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. Am Rev Respir Dis. 141:1990;626-630.
-
(1990)
Am Rev Respir Dis
, vol.141
, pp. 626-630
-
-
Heifets, L.B.1
Lindhom-Levy, P.2
Flory, M.A.3
-
28
-
-
0032929038
-
Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids
-
Peloquin C.A., Namdar R., Singleton M.D., Nix D.E. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids. Chest. 115:1999;12-18.
-
(1999)
Chest
, vol.115
, pp. 12-18
-
-
Peloquin, C.A.1
Namdar, R.2
Singleton, M.D.3
Nix, D.E.4
-
29
-
-
0031596346
-
Disposition and metabolism of 14C-rifapentine in healthy volunteers
-
Reith K., Keung A., Toren P., Cheng L., Eller M., Weir S. Disposition and metabolism of 14C-rifapentine in healthy volunteers. Drug Metab Dispos. 26:1998;732-738.
-
(1998)
Drug Metab Dispos
, vol.26
, pp. 732-738
-
-
Reith, K.1
Keung, A.2
Toren, P.3
Cheng, L.4
Eller, M.5
Weir, S.6
-
30
-
-
0016277961
-
Binding of rifampicin by human plasma proteins
-
Boman G., Ringberger V.A. Binding of rifampicin by human plasma proteins. Eur J Clin Pharmacol. 7:1974;369-373.
-
(1974)
Eur J Clin Pharmacol
, vol.7
, pp. 369-373
-
-
Boman, G.1
Ringberger, V.A.2
-
31
-
-
0036606533
-
Tolerability of once-weekly rifapentine 900 mg plus INH vs once-weekly rifapentine 600 mg plus INH during continuation phase treatment of pan-susceptible tuberculosis in HIV-negative adults
-
the Tuberculosis Trials Consortium, Bock N.N., Conwell D.S., Pachucki C.T., Sterling T.R., Wang Y.C. Tolerability of once-weekly rifapentine 900 mg plus INH vs once-weekly rifapentine 600 mg plus INH during continuation phase treatment of pan-susceptible tuberculosis in HIV-negative adults. Am J Respir Crit Care Med. 165:2002;1526-1530.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 1526-1530
-
-
Bock, N.N.1
Conwell, D.S.2
Pachucki, C.T.3
Sterling, T.R.4
Wang, Y.C.5
-
32
-
-
0005116073
-
A prevention effectiveness study of rifapentine in the continuation phase of therapy for active pulmonary tuberculosis
-
abstr
-
Taylor Z., Qualls N., Vernon A., Villarino E., O'Brien R. A prevention effectiveness study of rifapentine in the continuation phase of therapy for active pulmonary tuberculosis. Am J Respir Crit Care Med. 161:2000;A524. (abstr).
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. A524
-
-
Taylor, Z.1
Qualls, N.2
Vernon, A.3
Villarino, E.4
O'Brien, R.5
-
33
-
-
0026098628
-
A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong
-
Hong Kong Chest Service, Tuberculosis Research Centre Madras, and British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis 1991; 143: 262-67.
-
(1991)
Am Rev Respir Dis
, vol.143
, pp. 262-267
-
-
|